Table 1.
Summary of clinical information and experimental results.
patient | HCC_ID | Clin. Diag. | HBsAg | HCV-Ab | p53 | beta-catenin | GMA | common aberration | r | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 |
2 |
MC |
- |
+ |
2.45 |
+ |
0.87 |
|||||||
4 |
||||||||||||||
2 |
6 |
MC |
+ |
- |
R273H |
S33C |
0 |
- |
0.63 |
|||||
8 |
||||||||||||||
3 |
10 |
MC |
- |
+ |
2.24 |
- |
0.22 |
|||||||
12 |
Q129stop |
|||||||||||||
4 |
14 |
MC |
- |
+ |
R249S |
8.49 |
+ |
0.7 |
||||||
16 |
S183stop, E298stop |
|||||||||||||
5 |
18 |
MC |
- |
+ |
S33C |
3.16 |
- |
0.8 |
||||||
21 |
||||||||||||||
6 |
102 |
MC |
- |
+ |
Q245C |
4.9 |
- |
0.83 |
||||||
104 |
R249S |
Q34E |
||||||||||||
7 |
106 |
IM |
- |
+ |
0 |
- |
0.82 |
|||||||
108 |
||||||||||||||
8 |
110 |
IM |
- |
+ |
8.94 |
+ |
0.82 |
|||||||
112 |
||||||||||||||
9 |
114 |
MC |
+ |
- |
14.8 |
+ |
0.21 |
|||||||
116 |
||||||||||||||
10 |
26* |
MC |
- |
+ |
0 |
- |
0.27 |
|||||||
27* |
||||||||||||||
11 |
29* |
IM |
- |
- |
Q34E |
2 |
- |
0.9 |
||||||
30* |
V22G,S33S,I35S |
|||||||||||||
12 |
32* |
IM |
+ |
- |
R175H |
0 |
- |
0.87 |
||||||
33* |
||||||||||||||
13 |
35* |
MC |
- |
+ |
Y163N |
D32G |
10 |
+ |
0.63 |
|||||
36* |
T41I |
|||||||||||||
14 |
38* |
MC |
- |
+ |
F278A |
14.3 |
+ |
0.4 |
||||||
39* |
||||||||||||||
15 |
41* |
MC |
+ |
- |
1.41 |
- |
0.76 |
|||||||
42* |
*, tumors dissected at the same operation. Others were sampled at different operations.
GMA, geometric mean of number of chromosomal aberrations; common aberrations, common chromosomal aberrations found in tumors from same patients; r, correlation coefficient of methylation patterns of tumors from same patients.